Curated summary · agent-written · kb/genes/curated/hgnc_7631.md
All 12 claims checked against the KB draft

NAGA across dismech

NAGA (alpha-N-acetylgalactosaminidase) is named by 3 disorder entries, the three clinical forms of NAGA deficiency: Kanzaki Disease; NAGA Deficiency Type 3; and Schindler Disease.

Normal function

NAGA encodes the lysosomal exoglycosidase that removes terminal alpha-N-acetylgalactosamine from glycopeptides and glycolipids. The pinned ai-gene-review snapshot has no core functions for NAGA yet (0 terms); an upstream review is being added.

Causative records

All three entries type NAGA as causative: Kanzaki Disease; NAGA Deficiency Type 3; Schindler Disease, with the variants recorded as germline in each (Kanzaki Disease; NAGA Deficiency Type 3; Schindler Disease). In NAGA Deficiency Type 3 the gene sits on the node Alpha-N-Acetylgalactosaminidase Deficiency, which conforms to the module lysosomal_substrate_accumulation. The KB annotates NAGA nodes with glycoprotein catabolic process.

Where the layers disagree

ClinGen classifies NAGA for 1 disease, the umbrella alpha-N-acetylgalactosaminidase deficiency, which no dismech entry carries as its disease term; the three entries are the narrower clinical forms, so the ClinGen tier is not copied onto any of them.

Underlined values are claims re-computed from the knowledge base each time this page is built. The tables below are the source of truth.

In the knowledge base · computed from kb/ at build time

Disorders

Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.

DisorderRelationshipWhere the gene appears
Kanzaki Disease causative germline
mechanism: Alpha-N-Acetylgalactosaminidase Deficiency
NAGA Deficiency Type 3 causative germline
mechanism: Alpha-N-Acetylgalactosaminidase Deficiency
Schindler Disease causative germline
mechanism: Alpha-N-Acetylgalactosaminidase Deficiency
ClinGen gene–disease validity · snapshot 2026-10-03 · matched to entries by MONDO

An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.

ClinGen diseaseMOIClassificationdismech entry
alpha-N-acetylgalactosaminidase deficiency MONDO:0017779 AR Definitive
2022-09-29
no dismech entry
Mechanism modules · computed from kb/

Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.